Patent details
EP1004298 Title: Controlled release tablet of bupropion hydrochloride
Basic Information
- Publication number:
- EP1004298
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP994024552
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Controlled release tablet of bupropion hydrochloride
- French Title of Invention:
- Comprimés contenant du chlorhydrate de bupropione à libération controllée
- German Title of Invention:
- Bupropionhydrochlorid enthaltende Tabletten mit gesteuerter Wirkstoffabgabe
- SPC Number:
Dates
- Filing date:
- 07/10/1999
- Grant date:
- 09/06/2004
- EP Publication Date:
- 09/06/2004
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 31/05/2000
- EP B1 Publication Date:
- 09/06/2004
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 07/10/2004
- Expiration date:
- 07/10/2019
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 07/10/1999
- Name:
- Biovail Laboratories Incorporated
- Address:
- Chelston Park, Building 2, Colleymore Rock, St. Michael, BH1, Barbados (BB)
Inventor
- Name:
- Seth Pawan
- Address:
- United States (US)
Priority
- Priority Number:
- 184096
- Priority Date:
- 30/10/1998
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 9/32;
| Filing date | Document type | Number of pages |
|---|